Outlook Business’ stock wizards put up a strong show in CY2014 with an average return of 87%. Let us see how they have fared in the first quarter of CY2015
Posts tagged Shilpa Medicare
What We Can Learn From Daljeet Kohli’s Mistakes In Ajanta Pharma & Shilpa Medicare
Daljeet Kohli’s experience with Ajanta Pharma and Shilpa Medicare shows that it is not enough to identify winning stocks. To reap the full benefit, we must have the sagacity to remain invested inspite of temporary periods of over-valuation and adversities
Are You Still Taking Raamdeo Agrawal’s 100-Bagger Stocks For Granted?
Shilpa Medicare’s spectacular jump of 17% today is not an isolated instance. Most of the stocks hand-picked by Raamdeo Agrawal as potential multi-baggers are sparkling
Ten Top Stock Picks For 2015 From Ten Top Ace Stock Pickers
Outlook Business deserves to be commended for persuading ten ace stock pickers to name their favourite stocks for 2015. We need to take advantage of the bonanza
Daljeet Kohli Previews Q3FY15 Results Of Top Pharma Companies
Daljeet Kohli of IndiaNivesh has issued a comprehensive report previewing the Q3FY15 results of 18 pharma companies and given clear-cut buy, sell and hold recommendations
Daljeet Kohli Rakes In Mega Bucks From Favourite Stocks. He Promises More Gains For Us In 2015
Daljeet Kohli has been on a winning streak in 2014. His winning stocks outnumber his losing stocks by a wide margin. He has promised more gains for us in 2015
The Stock Picks Of Niraj Dalal & Manish Bhandari
Niraj Dalal of 3A Capital Advisors and Manish Bhandari of Vallum Capital have indicated their favourite stock picks in an interview to CNBC TV18
Shilpa Medicare Gives Mega Gains But Daljeet Kohli Downgrades It To Hold
Shilpa Medicare’s relentless surge has caused Daljeet to sound a note of caution. He has downgraded the price target and advised a hold of the stock
Did You Miss Out On Multi-Baggers Handed Over On A Platter? Don’t Make The Mistake Again!
Last year, Motilal Oswal’s 18th Wealth Creation Study gave us five multi-bagger stocks on a platter. If we didn’t act on the advice and grab the stocks, we have ourselves to blame. We should not miss out on such opportunities in future because even their current stock picks appear likely to outperform by a wide margin
Sharon Bio-Medicine Price Target Slashed & Downgraded To Hold: Daljeet Kohli
Daljeet Kohli has slashed the target price of Sharon Bio-Medicine from Rs. 140 to Rs. 66. Though there is still a huge potential upside, he has downgraded the stock to ‘Hold’ to await clarity of future events
Recent Comments